1.

7 COMPETITOR
ANALYSIS
UX I MMERS I ON
MAS HA BAL AG AN OVA, FEB 1 5 , 2 0 2 3
MEDISAFE
 MediSafe
1 OVERVI EW
Med i S af e i s a di g i t al dr ug c o mpa ni o n that hel ps
mon i t or hea l th c on di ti on a n d a l s o a l l ows pa t i en t s
manag e hos pi t al app o i nt me nt s , conne ct w i t h
doc t or s and c a r e g i v e r s .

2 MI S SI ON & VI S I S O N
“ Se aml e ssl y ma na g e t he me d i cat i on j our ne y ” i s
the i r mi ssi on . Th e v i s i on i s “ Empowe r pa t i e nt s by
dar i n g t o r e i ma g i ne t he t r e at me nt j our ne y . ”
 MediSafe
3 SOLUTI ONS
Vi s ual and e a s y medi c a l ma n a ger t o
han dl e drug remi n ders
I nteg rati on wi th oth er h ea l t h a pps l i k e
Heal t h Ki t
R ep ort shari n g i n PDF
Fami l y accoun t to ma n a ge a l l t h e pi l l
box es f rom o n e p l a c e
Var i o us f unny ton es f or remi n d ers
S mart remi n ders th a t work ev en i n s l eep
mod e and co n s i der ti me z on e ch a n ges
R ef i l l remi nd ers
S i d e e f f ects a n d mi x i n g pi l l s i n f orma t i on
 MediSafe
4 OVERALL ST R AT EGY
Med i S af e reg ul a rl y up dat es t h ei r web s i t e n ews l e tter , m a inl y e mp hasi z e s
on t he r e l i ab l e s o f t w a r e that keeps pa ti en t’ s da ta s a f e, t h e promot e
s of t war e as a me di c a l de v i ce an d seem to be qui te f amous i n m e di c a l
i nd ust r y si nce t he pl atf orm f or doct ors a n d pa t i en t s i s n o t the o nl y
p r o duct they of f er. Th ey a l s o pos t n e ws o n L i nk e dI n ab out rewar ds th ey
g et and upda tes on th ei r prod uct s .
 MediSafe
5 MAR KET AD VAN T AGE
The ad v anc e d t e c hno l o g y s up p or t t hat p rovi de s us ers wi th s moot h app
i nt e r ac t i on and da t a s afe t y i s wh at they h i g h l i g h t. AppS t ore # 7 9 i n
und er “pi l l re mi n der” c a tegory. Ra t i n g i n App St or e 4. 7 / 5 wi th ove r 7 6k
r e v i e ws, whi l e i n Googl e Pl ay i t ’ s 4 . 6 / 5 and ove r 2 0 0 k v o t e s . Thi s s eems
to be t hei r mai n s our c e o f ne w u s e rs , si nce the ra ti n g does n ’ t d i f f er
much, i t mi g h t mea n th e a pp work s q ui t e wel l f or b ot h i OS and Andr oi d.
 MediSafe
6 MAR KETI NG R O F I L E
“The Worl d' s Le a di ng Me d i c a t i o n Engag e me nt P l at for m and Mobi l e
Ap p ” t hat’ s t h e wa y th ey pos i t i on t h ems el v es . The w eb site sta tes tha t
the s of tware i n c l udes v ari ous us e r b e havi o r a l a l g o r i t hms that makes UI
eas y f or peop l e wi th di f f eren t h ea l t h prob l ems . I n 2021 they r eceiv ed
“ Be st onl i ne me di c a l a pp” aw ar d .
 MediSafe
7 STR ENGTH OPPORTUN I T Y
Strong algori thm Increase app awareness through
Simple in use interface social
High user protection media like Instagram/Facebook
Brand recogni tion i n adds
pharmaceuticals and medical s uppl y Make an interface more appea l in g,
industry now it looks quite strict
Add educational aspect in the a pp
WEAKNESS THR EAT
Boring interface Other pill trackers and al l kinds of
Lack of some UX functions l ik e v ideo alarms with reminders
call or reminders to take n ote in Paper diary/dai l y pl anner
diary
Lack of functions for menta l h ea l th
well being tracking
MYTHERAPY
 MyTherapy
1 OVERVI EW
MyT herapy i s a fr e e p i l l - r e mi nde r an d me d i c at i on
t r ac ke r that al l ows us ers to ma na ge h ea l t h h i s t ory,
not e p ati ent ’ s c on di ti on s i n a d i a ry a n d ma k e
ap p oi n tments wi th doc to rs .

2 MI S SI ON & VI S I S O N
Me d i c at i on r e mi nde r s . A nd s o much mor e ” - i s t he
mi ssi o n whi l e " My The r apy : Y o u r pe r s onal p i l l
r e mi n de r and me di c a t i on t r ack e r ” i s t he vi si on.
 MyTherapy
3 SOLUTI ONS
Pi l l r emi nder s a n d i n j ec t i on t ra ck i n g
Eas y t o use ev en f or h i gh compl exi t y
dos ag e
R ef i l r emi nd ers
PDF r eports
Per sonal i z ed ti p s f or tre a t men t
Wi d e- rang e of mea s uremen t s
Ad- f ree servi c e
 MyTherapy
4 OVERALL ST R AT EGY
On the websi te th ey p ro mot e i mport a n ce of d a t a s afe t y, r e s e a r c h and
f r e e a vai l ab i l i t y as t hei r adva n ta g es . H owev er, t h e wa s s ome s ecu r ity
v ul nerabi l i ti es f oun d i n 20 2 2 .

5 MAR KET AD VAN T AGE

MyT herapy i s f r e e a pp an d doe sn' t c ont a i n a ny a ds, t hi s i s what s ets
t he m apart. Th e Th e a p p c ome s out fi r s t whe n I typed p i l l tra c k er, i n
Ap p St or e i t has 4 . 9 / 5 r ati ng and a l mos t 3 k r e vi e ws. Googl e Pl ay r ati ng
4 . 7 wi t h 1 4 7 K r e vi e w s .
 MyTherapy
6 MAR KETI NG PR O F I L E
The websi te h i g h l i g h ts c ol l a bor at i ons wi t h wi th bi g a n d f a mous
compani es i n me d i c al fi e l d an d p ha r mac e ut i c a l s . My Therapy wa s a l s o
men ti o ned on s ome t v c hanne l s, but commerc i a l v i deo i s n ot a v a i l a b l e
onl i n e. The ne wsl e t t e r on t he websi te up da tes on ce i n a wh i l e, no
pr e se nc e on po pu l a r s o c i al me d i a p l at for ms has b een f ou n d ex c ep t
Li n kedI n. Pos s i bl y, c ol l ab ora t i on s wi t h ph a rma ce u tica l s l ike Shop
Apot he ke i n Germany a n d s ome me d i c al i nst i t u t i o ns ar e one of th ei r
mai n s ource of a p p a war e ne s s .
 MyTherapy
7 STR ENGTH
Simple and i ntuitive des ign
Useful functions that cov er n eeds of
a big group of patients
WEAKNESS
Some UX probl ems that needs to be
adjusted like customized symptom
trackers or pi l l reminders a utomatic
change when a person wa s l ate to
take their meds on time.
No function to connect or cal l a
doctor or caregiver
No info on mixing pi l l s an d th eir
side affects
OPPORTUN I T Y
Add a messenger function to
connect with a doctor
Add informative aspect about
maintaining healthy l ifestyl e
Become more present on social
media through educating peopl e
about life on meds to increase a pp
awareness
THR EAT
Other pill trackers and al l kinds of
alarms with reminders
Paper diary/dai l y pl anner
 MyTherapy
USABI LI TY A N AL Y S I S

USABI LI TY

The app des i g n i s s i mp l e a n d ea s y t o us e mos t l y d u e to a b sence o f f u nctio na l

compl e xi ty o f s uc h a p p s. A f t er d own l oa d i n g, n o a p p to u r o r g u id ing o f f er ed
whi ch makes us ers l ook f or n eces s a ry f un ct i on s them sel v es. H o w ev er , f o r
some users i t ma y be i mport a n t t o s ee s ome a pp intr o to a d ju st so o ner .

 MyTherapy
USABI LI TY A N AL Y S I S

LAY OUT

S p ace on ho me p a g e “Tod a y” l ook s a b i t

und eruti l i z ed a n d l a c k i n g gui d a n ce, a s a n ew us e r ,
I ’ d appreci ate s ome n ote wi t h a n expl a n a t i on wha t I
can d o here, h ow a n d wh y. O r s ome ev eryd a y h e a l th
ti p s coul d be a g ood a s s et t oo. Col or pa l l et i s n ot
v er y stri ct o r da rk , g i v es s omewh a t a coz y f eel i ng ,
i t has cute i ma g es too.

 MyTherapy
USABI LI TY A N AL Y S I S

NAVI GATI ON S T R U CT U RE

The l og i c of th e s truc tur e i s cl ea r h owev er s i n ce

the re’ s no g ui da n c e, I n eed ed s ome t i me t o f i n d
how t o add my tra c k i n g . A b i gger b ut t on wi t h “+ ”
woul d hel p ( A) .
I f a user nee ds to a dd a n y d a i l y a ct i v i t i es t o a
cal endar, they h a v e to g o t o “t rea t men t ” ca t egor y,
however acti v i ti es th ere a re n ot d i rect l y rel a t ed to
tr eatment. Ch a n g i n g i t i n t o j us t “A ct i v i t y” woul d
make i t more c l ea r ( B) .
( A) ( B)
 MyTherapy
USABI LI TY A N AL Y S I S

COMPATAB I L I T Y

The app i s a v a i l a bl e f or i O S a n d A n d roi d us ers .

DI F FERENTI AT I O N

MyT herapy prov i des more gen eri c s ol ut i on s f or p il l tr a cking a nd hea l th m a inta ining .
R ev i e ws on A p p S tore a n d Googl eP l a y s ugges t ed to a d d m o r e cu sto m ized f u nctio ns:
act i v i t y l i st an d tra c k i n g mea s uremen t s curren t l y d o n’ t a l l o w u ser s a d d so m ething
that i s not sug g es ted by t h e a pp, t h e s a me i s wi t h the to ne r em ind er s, it’ s v er y
l i mi t ed and not p os s i bl e t o us e your f a v ori t e s ong o r r a d io f o r it. 5A0m 0 o r/e YEAR
0 p er so na l ized
6 0 0 0 / YEAR
ap p roach mi g h t a ttra c t more us ers t o t ry a n ew a p p a nd stick to it.
 MyTherapy
USABI LI TY A N AL Y S I S

DI F FERENTI AT I O N

The mai n f eature th a t c o ul d ma k e a n ew a pp s t and o u t is a l l o w ing u ser s co nnect w ith

the i r d octors or c a reg i v e rs t h rough t h e a pp v i a c a l l s o r v id eo , it m ig ht b e im p o r ta nt
i n case of emerg en c y or wh en a pers on i s n ot mo b il e a nd ca n’ t v isit a ho sp ita l b u t
nee ds some up da tes f rom t h e d oct or.

One more i mp orta n t f unct i on coul d b e a d d i n g a v o ice r eco r d ing f u nctio n tha t
con verts the rec ordi n g i n t o t ext f or d a i l y n ot es f o r p eo p l e w ho m ig ht ha v e p r o b l em s
wi t h hands o r f i n g er mov emen t s .

 MyTherapy
USABI LI TY A N AL Y S I S

DI F FERENTI AT I O N

Al so, si nce t h e i dea of th e mi s s i on of t h e a pp i s to p r o m o te m a inta ining w el l -b eing , it

i s i mportant to educ a te us ers , a f un ct i on wi t h a v a il a b l e inf o r m a tio n r eg a r d ing u ser ’ s
heal t h probl em or g en er a l h ea l t h t i ps , f or t h a t a new a p p ca n d o a co l l a b o r a tio n w ith
some r el ated I G a c c oun t s or Y out ub e ch a n n el s f o r hig ht a p p a w a r eness.

 MyTherapy
USABI LI TY A N AL Y S I S

CALL TO ACT I O N

S i nce the ap p i s f ree a n d ca n b e us ed i n a gues t m o d e to o , u ser s a r e no t r eq u ir ed to

i np ut any co n ta c t i n f orma t i on or b uy s ub s cri pt i o n.

 KEY TAKEAWAYS

Use rs are l ook i n g f or a p ers on a l t ouch a n d wa n t to b e a b l e to

hav e s ome c us t omi z e d f e a t u r e s a s ad d - ons.
Non e o f the a n a l ys ed c ompet i t ors h a v e a f un ct i o n o f vi d e o c al l s
nor qui c k me s s a g e s , i t coul d be US P.
Competi tors do n ot ta k e a d v a n t a ge of s oci a l med ia , w hich m ig ht
be a g ood opp ortun i ty f or a n ew prod uct t o gai n a pp awa r e ne s s
and attract u s ers wi th w el l -b ei n g ed uca t i on a s pe ct.